Replies to post #162997 on Cytodyn Inc (CYDY)

[DonDonDonDon]

why a man with no biotech experience decides to suddenly buy an abandoned drug

I've always felt that there is a group propping Nader up. The group actually makes more money from Nader's incompetence because the screwups cause huge swings in share price. With advance knowledge of the screwups, it would be easy to make a bundle.

Leronlimab was the perfect drug to choose for a biotech that didn't really have any intention of developing a drug. Its safety profile is the gold standard. It probably has some slight anti-inflammatory properties. Any small trial can be sliced and diced to highlight what appears to be efficacy. But those bright spots are actually attained through random chance. And CYDY shareholders aren't savvy enough to know the difference. CYDY is the biotech equivalent of a TV infomercial.